alpha-aminopyridine has been researched along with B16 Melanoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, TY; Hsiao, YP; Huang, SJ; Ko, JL; Leong, PY; Lu, CT | 1 |
| Hyun, H; Lyle, LT; Pang, L; Pei, Y; Uzunalli, G; Yeo, Y | 1 |
| Iannone, R; Maiolino, P; Miele, L; Morello, S; Pinto, A | 1 |
| Bollag, G; Graeber, TG; Hu-Lieskovan, S; Koya, RC; Mok, S; Ribas, A; Tsoi, J; West, BL | 1 |
| Ahn, YM; Booth, RJ; Caldwell, TM; Chun, L; Clare, M; Ensinger, CL; Flynn, DL; Hood, MM; Kaufman, MD; Leary, CB; Lu, WP; Patt, TW; Patt, WC; Rutkoski, TJ; Samarakoon, T; Smith, BD; Stewart, LJ; Telikepalli, H; Turner, BA; Vogeti, L; Vogeti, S; Wise, SC; Yates, KM | 1 |
| Miele, L; Morello, S; Pinto, A; Porta, A; Sorrentino, C | 1 |
| Geisslinger, G; King-Himmelreich, TS; Laarmann, K; Meissner, M; Möser, CV; Niederberger, E; Olbrich, K; Wolters, MC | 1 |
| Boyapalle, S; Cress, WD; Guida, W; Kurtyka, CA; Lawrence, H; Ma, Y; Sung, SS | 1 |
8 other study(ies) available for alpha-aminopyridine and B16 Melanoma
| Article | Year |
|---|---|
Ganoderma immunomodulatory protein and chidamide down-regulate integrin-related signaling pathway result in migration inhibition and apoptosis induction.
Topics: Aminopyridines; Animals; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Ganoderma; Human Umbilical Vein Endothelial Cells; Humans; Integrin alphaV; Male; Melanoma, Experimental; Mice, Inbred C57BL; Neoplasm Metastasis; Signal Transduction | 2018 |
Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages.
Topics: Aminopyridines; Animals; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Humans; Macrophages; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Peptides; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrroles; RAW 264.7 Cells | 2019 |
Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.
Topics: Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemokine CCL2; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Female; Immunosuppressive Agents; Interleukin-10; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Natural Killer T-Cells; Neoplasm Transplantation; Receptor, Adenosine A2B; Tumor Burden; Tumor Escape; Tumor Microenvironment; Xanthines | 2013 |
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Indoles; Lymphocyte Activation; Macrophages; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Proto-Oncogene Proteins B-raf; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Sulfonamides; T-Lymphocytes; Vemurafenib | 2015 |
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2.
Topics: Aminopyridines; Anilides; Animals; Antineoplastic Agents; Bevacizumab; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Design; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Hepatocyte Growth Factor; Humans; Inhibitory Concentration 50; Melanoma, Experimental; Mice; Models, Molecular; Molecular Conformation; Monocytes; Neovascularization, Pathologic; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Receptor, TIE-2; Recombinant Proteins; Stromal Cells; Tumor Microenvironment; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2015 |
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model.
Topics: Aminopyridines; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Antigens, Ly; CD11b Antigen; Disease Models, Animal; Female; Flow Cytometry; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Neovascularization, Pathologic; Receptor, Adenosine A2B; Skin Neoplasms; T-Lymphocytes; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2015 |
The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model.
Topics: Aminopyridines; Animals; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; I-kappa B Kinase; Melanocytes; Melanoma; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Pain; Skin Neoplasms | 2016 |
A small-molecule E2F inhibitor blocks growth in a melanoma culture model.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; E2F Transcription Factors; Hydroxyquinolines; Melanoma, Experimental; Mice | 2008 |